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Abstract: We have isolated a cDNA coding for a putative invertebrate-type dopamine 
receptor (Peadop2) from P. americana brain by using a PCR-based strategy. The mRNA is 
present in samples from brain and salivary glands. We analyzed the distribution of the 
PeaDOP2 receptor protein with specific affinity-purified polyclonal antibodies.  
On Western blots, PeaDOP2 was detected in protein samples from brain, subesophageal 
ganglion, thoracic ganglia, and salivary glands. In immunocytochemical experiments,  
we detected PeaDOP2 in neurons with their somata being located at the anterior edge of 
the medulla bilaterally innervating the optic lobes and projecting to the ventro-lateral 
protocerebrum. In order to determine the functional and pharmacological properties of the 
cloned receptor, we generated a cell line constitutively expressing PeaDOP2. Activation of 
PeaDOP2-expressing cells with dopamine induced an increase in intracellular cAMP.  
In contrast, a C-terminally truncated splice variant of this receptor did not exhibit any 
functional property by itself. The molecular and pharmacological characterization of  
the first dopamine receptor from P. americana provides the basis for forthcoming studies 
focusing on the significance of the dopaminergic system in cockroach behavior  
and physiology. 
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1. Introduction 
Cockroaches (Blattodea) not only belong to the oldest winged insects (Pterygota), but also represent 
well-established model organisms for basic research in neurobiology and physiology [1]. Because of 
their large size, simple animal maintenance, and their role as pest insects, Periplaneta americana and 
related species are well suited for studying the morphology, physiology, and pharmacology of the 
insect nervous system. Such research has led to a better understanding of circadian rhythmicity ([2,3]; 
for a review, see: [4]), the neural basis of escape behavior (for a review, see: [5]), and neuropeptide 
distribution and action (for a review, see: [6]). Because of the ready accessibility of intact mini-organs 
for various kinds of opto- and electro-physiological recordings, cockroaches are also used to study 
epithelial physiology and to investigate the cellular actions of biogenic amines ([7–10]; for reviews, 
see: [11,12]). In addition, various learning paradigms have been established for P. americana during 
the last few years [13–17]. 
The biogenic amine dopamine is the only physiologically relevant catecholamine in insects  
(for reviews, see: [18,19]) in which it is found in relatively large amounts in the central nervous  
system and in peripheral organs [20,21]. The distribution of dopaminergic nerve fibers has been 
immunohistochemically mapped in the brain of P. americana [22–24] and various other insects  
(e.g., Drosophila melanogaster: [25]; Apis mellifera: [26,27]; Schistocerca gregaria: [28]). 
Dopaminergic fibers also innervate the salivary gland complex in locusts and cockroaches ([29,30];  
for a review, see: [31]). Various insect behaviors are modulated by dopamine. In D. melanogaster,  
for example, genetic and pharmacological analyses have demonstrated the importance of dopamine in 
sleep, arousal, light perception, circadian entrainment, feeding, and aversive conditioning [32–40].  
In addition, dopamine might contribute to the regulation of larval motor function in  
D. melanogaster [41,42]. Furthermore, dopamine is involved in the regulation of exocrine [7,8,43,44] 
and endocrine [45,46] secretion. 
Most dopamine receptors belong to the superfamily of G-protein-coupled receptors (GPCRs).  
In mammals, two subfamilies of dopamine receptors have been distinguished by their pharmacological 
properties and intracellular signaling pathways: D1-like (D1 and D5) and D2-like (D2, D3, and D4) 
receptors (for reviews, see: [47,48]). D1-like receptors activate adenylyl cyclase, whereas members of 
the D2-subfamily either inhibit adenylyl cyclase or couple to different intracellular second messenger 
systems. D1-like (=DOP1) and D2-like (=DOP3) receptors have also been characterized in  
D. melanogaster [49,50], A. mellifera [51,52], and other insect species. In addition, a third subfamily 
of dopamine receptors (=DOP2) is present in insects [53–56]. Similar to D1-like receptors,  
these “invertebrate type dopamine-receptors” (INDRs; for a review, see: [19]) also activate adenylyl 
cyclase. Phylogenetically, however, they are more closely related to α-adrenergic-like octopamine 
receptors expressed in insects. The classification system for insect octopamine receptors into  
α-adrenergic-like octopamine receptors, β-adrenergic-like octopamine receptors and tyramine  
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(or octopamine/tyramine) receptors was introduced based on their similarities in structure and in 
signaling properties with mammalian adrenergic receptors [57]. INDRs and α-adrenergic-like 
octopamine receptors also seem to couple not only to cAMP, but also to Ca2+ signaling, and to share 
pharmacological properties [58]. 
In cockroaches, information has been accumulated on the pharmacological properties of dopamine 
receptors in salivary glands and other tissues (for reviews, see: [12,21]). In contrast, comparatively 
little is known about the exact repertoire and molecular properties of aminergic receptors in  
P. americana [59–61], and, until this study, no molecular data on dopamine receptors have been 
available. Here, we show that the mRNA encoding an INDR, which we term PeaDOP2, is expressed in 
the brain and salivary glands of P. americana. Immunohistochemical analysis has shown that the 
receptor protein is present in specific brain neurons with their somas being located at the anterior  
edge of the medulla. When stably expressed in human embryonic kidney (HEK) 293 cells,  
PeaDOP2 promotes the formation of cAMP with an EC50 of 160 nM for dopamine. The effect of  
dopamine is mimicked by (±)-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN)  
and (±)-6-Chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (6-chloro-APB) 
and abolished by co-incubation with known dopamine receptor antagonists, e.g., chlorpromazine and 
cis(Z)-flupentixol. This study marks the first comprehensive molecular, pharmacological, and 
functional characterization of a dopamine receptor in the cockroach and furthers the understanding of 
biogenic amine signaling in this model insect. 
2. Results 
2.1. Molecular Cloning and Sequence Analysis of a Dopamine Receptor from P. americana 
Using degenerate oligonucleotide primers for highly conserved GPCR transmembrane (TM) 
regions 6 and 7, we amplified a cDNA fragment of 109 bp from P. americana brain cDNA coding for 
a putative dopamine receptor. Rapid amplification of cDNA ends (RACE) was undertaken with  
gene-specific primers in order to obtain the missing 5' and 3' parts of the putative Peadop2 cDNA  
(see Experimental Section). The full-length cDNA consists of 1815 nucleotides (Peadop2A; Accession 
No.: HG794355) and was independently amplified as a complete fragment by using two gene-specific 
primers. The longest open reading frame encodes a protein of 512 amino acids (PeaDOP2A) with a 
predicted molecular mass of 57.7 kDa. In addition, we identified a truncated splice variant of 
Peadop2A, which we named Peadop2B and which possessed an alternative C-terminal region. The 
nucleotide sequence of Peadop2B is 1470 bp in length (Accession No.: HG794356), and the longest 
open reading frame encodes a protein of 456 amino acids (51.1 kDa). 
Analyses of the deduced amino acid sequences of both putative receptor variants with the topology 
predictor Phobius [62] revealed the expected hallmarks of GPCRs including structural features  
such as seven hydrophobic transmembrane domains, an extracellular N-terminus, and a cytoplasmic  
C-terminal region (Figure 1). Several highly conserved sequence motifs and amino acid residues 
among the aminergic GPCRs are found in the PeaDOP2 receptor variants. The aspartate residue D3.32 
according to the nomenclature of Ballesteros and Weinstein [63] in TM3 (D151 in PeaDOP2) is 
predicted to be relevant for binding the amine group of catecholamines such as dopamine, whereas 
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serine residues in TM5 form hydrogen bonds with the hydroxyl groups of dopamine [64,65].  
The characteristic C6.47-W6.48-x-P6.50-F6.51-F6.52 motif in TM6 (C404WLPFF), which interacts with the 
aromatic ring of dopamine, is also present. The PeaDOP2A/B receptors possess the D3.49-R3.50-Y3.51 
(D168RY) sequence located at the end of TM3 involved in receptor activation (for a review, see: [19]). 
Furthermore, the conserved N7.49-P7.50-x-x-Y7.53 (N443PxxY) motif in TM7, which is crucial for 
stabilizing the inactive conformation of the receptor, is present in both variants. Biogenic amine 
receptors are known to have numerous post-translational modifications. The N-terminal region of 
PeaDOP2A/B contains four consensus sites for N-linked glycosylation (N2GS, N32WS, N49FT, N55AS; 
Figure 1). One consensus site for phosphorylation by protein kinase C ([S/T]-x-[R/K]) occurs in  
CPL2 (S184VR) and four additional sites in CPL3 (S264LK, T282LR, S357TR and S378RK). The  
C-terminus of PeaDOP2A harbors three cysteine residues (C463VCC), which are highly conserved 
among INDRs and serve as potential targets for palmitoylation. In contrast, the short C-terminal region 
of PeaDOP2B does not contain any cysteine residues. 
Figure 1. Amino acid sequence alignment of PeaDOP2A and orthologous receptors  
from Drosophila melanogaster (DmDOP2A, NP_733299), Papilio xuthus (PxDOP2, 
BAD72870), and Apis mellifera (AmDOP2, AAM19330). Identical residues (≥75%) are 
shown as white letters against black, whereas conservatively substituted residues are 
shaded. Putative transmembrane domains (TM1–TM7) are indicated by gray bars. Potential 
N-glycosylation sites (▼), PKC phosphorylation sites (●), and putative palmitoylation sites 
(*) of PeaDOP2A are indicated. Underlined letters represent the region within the 3rd 
cytoplasmic loop from which the PeaDOP2-specific antigen was derived. R456 (†) is the last 
amino acid residue present in the truncated variant PeaDOP2B. The amino acid position is 
given on the right. 
                                        ▼                             ▼                         ▼     ▼             
PeaDOP2A                               MNGSLADSLWDEKQALGDGSADWNSAPGSHQNWSTSEDTFTE---------GITLDNNFTLDANASDENDV 62   
DmDOP2A   MVDDNGSSPEVEGAEGAGAPLLALLRVDGLNQTQTRSPSPSFFGSYNISEDVYFYFNGLPTSTELVLNATTSATSATLSPAMVATGGGGTTTPEPDLSEF 100  
PxDOP2                                 MNASEPEILVAKGQYEISQIGPEYIWESKAFNIGIEFNASFD------------NSTGYNITDNSAELWND 59   
AmDOP2                                 MNESAVYLLGSEEEGNQLNRSFYSASYPPQNRS----------------------------------QEED 37   
 
                  ___________TM1___________             ____________TM2_________            _______________TM3      
PeaDOP2A  AWELLQKRAPLAVLLLLFSVATVFGNMLVILAVIRERYLHTATNYFVTSLAVADCLVGLVVMPFSAVYEVLENRWFFGMDWCDVWRSLDVLFSTASILNL 162  
DmDOP2A   LEALPNDRVGLLAFLFLFSFATVFGNSLVILAVIRERYLHTATNYFITSLAVADCLVGLVVMPFSALYEVLENTWFFGTDWCDIWRSLDVLFSTASILNL 200  
PxDOP2    YIHLLQDRALLVTFLLLFSLTTVFGNMLVIMAVVRERYLHTSTNYFVTSLAVADCLVGLVVMPFSALYEVLEHTWFFGVDWCDVWRSLDVLFSTASILNL 159  
AmDOP2    LWNLATDRAGLAILLFLFSVATVFGNTLVILAVVRERYLHTATNYFVTSLAFADCLVGLVVMPFSAIYEVLENRWLFTTDWCDVWRSLDVLFSTASILNL 137  
 
          _____                ●    ____________TM4_______                   _________TM5____________               
PeaDOP2A  CVISLDRYWAITDPFTYPTRMSVRRAALLIAAVWVCSGAISFPAIVWWRAVRTEVVPAFKCPFTENLGYLVFSSTISFYLPLLVMVFTYYRIYRAAVIQT 262  
DmDOP2A   CVISLDRYWAITDPFSYPMRMTVKRAAGLIAAVWICSSAISFPAIVWWRAARDGEMPAYKCTFTEHLGYLVFSSTISFYLPLLVMVFTYCRIYRAAVIQT 300  
PxDOP2    CVISLDRYWAITDPITYPMRMSGRKAAFLIAAVWVCSGAISFPAIAWWRAVRLEEVPDYKCPFTENLEYIIFSSTISFYLPLFVMVFTYYRIYRAATIQT 259  
AmDOP2    CVISLDRYWAITDPFTYPSKMSRRRAAVLIAIVWICSSAISFPAIVWWRAVRTEEVPEDKCPFTEHLGYLIFSSTISFYLPLFVMVFTYYKIYRAAVIQT 237  
 
           ●                 ●                                                                            ● 
PeaDOP2A  RSLKLGSKQVMMASGELELTLRIHRGGNNSSSTNSGNTVVDDRHMYSSGSGGTPDELPGEVLDAADTMSPPHHHHHHH--HHHHHHHQNNGLTRHASTRI 360  
DmDOP2A   RSLKIGTKQVLMASGELQLTLRIHRGGTTRDQQNQVSGGGGGGGGGGGGGGSLSHSHSHSHHHHHNHGGGTTTSTPEEPDDEPLSALHNNGLARH----- 395  
PxDOP2    RSLKIGTKQVMRPSGELELTLRIHRGGTVRQRAD----------------------------------VCHGGCTPEEHDQEPLTALQNNGLSRS-STRL 324  
AmDOP2    KSLKLGTKQVLMASGELELTLRIHRGGGTNTDARHLF-----------------------------RTASSTPEDLQDLEEPLTTIQHNNCLTRIPSTRI 308  
 
                           ●               _____________TM6________           ___________TM7_________    †          
PeaDOP2A  MAGNTANSKAMSKNFSLSRKLAKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSGFCLRCIWNEELVSAVVTWLGWINSSMNPVIYACWSRDFRRAFVR 460  
DmDOP2A   --------RHMGKNFSLSRKLAKFAKEKKAAKTLGIVMGVFIICWLPFFVVNLLSGFCIECIEHEEIVSAIVTWLGWINSCMNPVIYACWSRDFRRAFVR 487  
PxDOP2    --TNVTHTKHLPKNFSLSRKLAKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSGICSSCITHEEIVNVVVTWLGWVNSSMNPVIYACWSRDFRRAFLR 422  
AmDOP2    -----NKQHTRGNNFSLSRKLAKFAKEKKAAKTLGIVMGVFIICWLPFFVVNLWSGFCSQCIWQEKIVFAAVTWLGWINSGMNPVIYACWSRDFRRAFVR 403  
 
            * **                                                     
PeaDOP2A  ILCVCCPRRMRRRYQPALRSKPSQYYGTP-MLQSNNPPSVSYSSVNQHELYSM 512  
DmDOP2A   LLCMCCPRKIRRKYQPTMRSK-SQCHVAAAMVAA--STSFGYHSVNQIDRTLM 537  
PxDOP2    ILCTCCPRKLRRKYQPQLRFKQSQLRTTRRYYSSSELVGIQQVRQNSCEQTYI 475  
AmDOP2    ILCACCPGRVRRRYQPAFRCKPSQRFASGRYYSAYSLHHVRSSRESSCEQTYI 456  
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BLAST searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi) with the PeaDOP2A sequence indicated 
that it shares pronounced homology with other invertebrate-type dopamine receptors (INDRs, for a 
review, see: [19]). High amino acid identity (ID)/similarity (S) is shared with receptors from  
Papilio xuthus (PxDOP2; ID 63%, S 71%; [66]), Apis mellifera (AmDOP2; ID 62%, S 69%; [55,56]), 
Ctenocephalides felis (CfDOP2A; ID 60%, S 71%; [67]), and Drosophila melanogaster (DmDOP2A; 
ID 58%, S 66%; [53,54]). These data reflect the high conservation level of dopamine receptors and 
especially of receptors of the INDR class (Figure 1). 
A multiple amino acid sequence comparison within the conserved transmembrane domains and 
short linker regions of PeaDOP2A in invertebrate and human dopamine receptors was used to calculate 
a phylogenetic tree (Figure 2). The PeaDOP2A receptor clustered with orthologous receptors of 
several insects and was incorporated into the branch of the INDRs. 
2.2. Tissue Distribution of Peadop2A and Peadop2B mRNA 
The expression pattern of Peadop2A and Peadop2B mRNA in various tissues of P. americana was 
investigated by RT-PCR with specific primers corresponding to sequences within the differing  
C-termini. Transcripts of Peadop2A and Peadop2B were detected in samples of the brain and salivary 
glands (Figure 3). Conversely, no receptor mRNA expression was detected in samples of  
Malpighian tubules, midgut, and leg muscle (Figure 3). To ensure that the fragments were not 
amplified from genomic DNA, samples were treated with DNase I. When tissue samples were treated 
additionally with an RNase cocktail, no PCR product could be amplified (data not shown). 
2.3. Generation of an Anti-PeaDOP2 Antibody and Immunohistochemical Localization of 
PeaDOP2A/B Receptors 
We generated a polyclonal antiserum directed against a part of the third cytoplasmic loop of 
PeaDOP2A/B receptors. Western blots of membrane proteins isolated from P. americana brain, 
subesophageal ganglion, thoracic ganglia, and salivary glands showed that the antibody recognized 
two bands of ~55 and ~46 kDa (Figure 4). These molecular weights are in accordance with the 
predicted molecular weights of 57.7 and 51.1 kDa for PeaDOP2A and PeaDOP2B, respectively.  
No bands were detected in protein samples isolated from the abdominal ganglia and the terminal 
ganglion (Figure 4). After pre-absorption with the peptide (15 µg/mL) used for immunization, the 
signal was completely lost (data not shown) supporting the specificity of the antibody for the 
PeaDOP2A and PeaDOP2B proteins. 
To investigate the cellular distribution of the PeaDOP2 receptors, cryosections of P. americana 
brains were examined with these antibodies (Figure 5). In frontal sections of anterior brain regions, 
specific labeling was found in a network of fibers in the ventral protocerebrum and in commissures 
running ventrally to the mushroom bodies (Figure 5A). In sections of central brain parts, prominent 
labeling also occurred in large parts of the optic lobes. A group of PeaDOP2-immunoreactive somata 
was located ventral to the medulla. These neurons sent projections radially via the medulla (not shown) 
to the lamina (Figure 5B). Additional fibers projected to the ventral protocerebrum and the optic 
commissure (Figure 5A,B). 
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Figure 2. Phylogenetic analysis of PeaDOP2A and various dopamine receptors. 
Alignments were performed with BioEdit (version 7.0.5) by using the core amino acid 
sequences lacking the variable regions of the amino and carboxy terminus and the 3rd 
cytoplasmic loop. The genetic distance was calculated with MEGA4. The receptor 
sequences, followed by their accession numbers, are listed in the order illustrated: 
Periplaneta americana PeaDOP2A (HG794356), Papilio xuthus PxDOP2 (BAD72870), 
Bombyx mori BmDOP2 (AB162716), Apis mellifera AmDOP2 (AAM19330),  
Drosophila melanogaster DmDOP2A (NP_733299), Ctenocephalides felis CfDOP2A 
(DQ459405), Panulirus interruptus PanDOP1a (DQ295790), human D1 (NP_000785), 
human D5 (NP_000789), Aplysia californica ApDOP1 (AY918891), PanDOP1b 
(DQ295791), AmDOP1 (CAA73841), DmDOP1 (AAA85716), BmDOP1 (AB362162), 
DmDOP3 (AAN15955), AmDOP3 (AY921573), PanDOP2 (DQ900655),  
human D4 (NP_000788), human D2 (NP_000786), human D3 (NP_000787),  
D. melanogaster ninaE-encoded rhodopsin 1 DmninaE (NM_079683), and  
D. melanogaster FMRFamide receptor DmFR (AAF47700). 
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Figure 3. Tissue distribution of Peadop2A/B mRNA. A 100 bp DNA ladder (marker) is 
shown on the left. Detection of PCR products amplified on total RNA isolated from brain, 
salivary glands, Malpighian tubules, midgut, and leg muscle. Amplification failed when 
samples were digested with an RNase cocktail prior to RT-PCR (data not shown).  
The lower panel shows RT-PCR products amplified with actin-specific (Accession No. 
AY116670) primers as a control. 
 
Figure 4. Western blot analysis with the anti-PeaDOP2 receptor antibody. Molecular 
weight marker in kilodalton. The anti-PeaDOP2-antibody (1:8000) recognized two bands 
of ~55 and ~46 kDa on Western blots containing membrane proteins (10 µg per lane) from 
brain tissue (br), subesophageal ganglion (seg), thoracic ganglia (thg), and salivary glands 
(sg). No bands were detected in samples from abdominal ganglia (abg) and the terminal 
ganglion (teg). 
 
  
Int. J. Mol. Sci. 2014, 15 636 
 
Figure 5. Immunohistochemical analysis of P. americana brain sections with the  
anti-PeaDOP2-antibody. Cryosections (20 µm) of the brain were labeled with primary 
antibody (anti-PeaDop2, 1:500). Secondary antibody was Cy2-conjugated goat anti-rabbit 
IgG (1:100). Images represent projections of image stacks and correspond to 10 µm. The 
outer margins of the sections are labeled with a stippled line. (A) Networks of fibers in the 
central protocerebrum are labeled in frontal sections of the anterior brain; (B) Somata and 
fibers in the optic lobe (ol) are labeled, in addition to fibers in the central protocerebrum 
(cp), in frontal sections of the central brain. al, antennal lobe. An enlargement is shown in 
the inset (B1). Scale bar in (A) and (B) is 500 µm, scale bar in (B1) is 10 µm. 
 
 
2.4. Functional Analyses of PeaDOP2A/B Receptors in HEK 293 Cells 
HEK 293 cell lines constitutively expressing PeaDOP2A or PeaDOP2B receptors were generated in 
order to examine their second messenger coupling and pharmacological properties. Expression of 
PeaDOP2A/B was confirmed by Western blotting and immunocytochemistry. The ligand specificity of 
the receptors was tested by the application of various biogenic amines (serotonin, dopamine, tyramine, 
octopamine, and histamine; 10 µM). Only dopamine significantly stimulated cAMP production in 
PeaDOP2A-expressing cells (300 pmol cAMP/mg protein; Figure 6A). None of the biogenic amines 
induced a change of the intracellular cAMP level ([cAMP]i) in the cell line stably expressing the 
PeaDOP2B receptor (Figure 6A). In PeaDOP2A-expressing cells, the dose-dependent effect of 
dopamine on [cAMP]i was analyzed with concentrations ranging from 1 nM to 10 µM (Figure 6B). 
The dopamine effect was concentration-dependent and saturable, resulting in a sigmoidal dose-response 
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curve (Figure 6B). Half-maximal stimulation of cAMP production (EC50) was achieved at a dopamine 
concentration of 160 nM (logEC50 = −6.78 ± 0.04, mean ± SEM). Maximal stimulation of cAMP 
synthesis was achieved at dopamine concentrations of ≥1 µM. None of the dopamine concentrations 
showed an effect on [cAMP]i in PeaDOP2B-expressing cells (Figure 6B) or in non-transfected cells. 
Figure 6. Modulation of intracellular cAMP levels [cAMP]i in HEK 293 cells stably 
expressing PeaDOP2A or PeaDOP2B receptors and in non-transfected cells. Data represent 
the mean of four to six values, and error bars indicate SEM and are, in some cases, too 
small to be seen. The statistical analysis is based on a one-way ANOVA followed by 
Dunnett’s multiple comparison test; * p < 0.05, ** p < 0.01. (A) Effect of the water-soluble 
forskolin analogue NKH 477 (an agonist of membrane-bound adenylyl cyclases) and 
various biogenic amines (10 µM) on [cAMP]i in non-transfected cells and in PeaDOP2A- 
or PeaDOP2B-expressing cells. The amount of cAMP is given as pmol cAMP/mg protein.  
To determine the basal [cAMP]i, cells were incubated with 100 µM IBMX only (basal). 
Asterisks indicate statistically significant differences for basal [cAMP]i versus  
drug-induced [cAMP]i for a given cell line; (B) Dose-dependent effect of dopamine  
(10−9 to 10−5 M) on [cAMP]i of PeaDOP2A- or PeaDOP2B-expressing cells; (C) Effects of 
dopamine receptor agonists (10 µM) on cAMP production in PeaDOP2A-expressing cells. 
The amount of cAMP is given as a percentage of the value achieved by stimulation with  
10 µM dopamine (=100%); (D) Dose-dependent effects of the highly potent PeaDOP2A 
receptor agonists 6,7-ADTN and 6-chloro-APB (10−9 to 10−5 M). The amount of cAMP is 
given as a percentage of the value achieved with 10 µM 6,7-ADTN or 6-chloro-APB 
(=100%); (E) Effects of dopamine receptor antagonists (10 µM) in the presence of 300 nM 
dopamine on cAMP production in PeaDOP2A-expressing cells. The amount of cAMP is 
given as a percentage of the value achieved with 300 nM dopamine (=100%);  
(F) PeaDOP2A-expressing cells were incubated with increasing concentrations (10-9 to  
10-5 M) of chlorpromazine, flupentixol, butaclamol, and SCH 23390 in the presence of  
300 nM dopamine. Relative fluorescence (%) is normalized to the values obtained with  
300 nM dopamine in the absence of antagonists (=100%). Of the antagonists shown, 
chlorpromazine displays the highest potency at PeaDop2A (IC50 = 2.7 nM). 
(A) (B) 
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Figure 6. Cont. 
(C) (D) 
 
(E) (F) 
Of the antagonists tested (10 µM in the presence of 300 nM dopamine), the non-selective  
dopamine receptor antagonists flupentixol (7.0%) and butaclamol (9.4%), the D2-receptor-antagonist 
chlorpromazine (8.6%), and the D1-receptor antagonist SCH 23390 (12.5%) inhibited the  
dopamine-induced increase (100%) of [cAMP]i almost to basal levels (8.6%; Figure 6E). Full  
dose-response curves were recorded for chlorpromazine, flupentixol, butaclamol, and SCH 23390 
(Figure 6F), and IC50 values are given in Table 1. 
Table 1. Agonist (EC50) and antagonist (IC50) profile of heterologously expressed 
PeaDOP2A receptor. For each substance, EC50 and IC50 values were derived from  
dose-response curves and are listed in order of their potency in increasing [cAMP]i and 
blocking dopamine (300 nM)-induced cAMP increase, respectively. 
Substance EC50/IC50 (nM) logEC50/log IC50 
agonists   
dopamine 163.3 −6.787 
6,7-ADTN 76.4 −7.117 
6-chloro-APB 381.9 −6.418 
antagonists   
chlorpromazine 2.7 −8.569 
flupentixol 6.5 −8.189 
butaclamol 326.0 −6.487 
SCH 23390 1786.0 −5.748 
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3. Discussion 
Aminergic receptors constitute a subfamily of rhodopsin-like GPCRs. The biogenic amine 
dopamine is found in deuterostomes and in protostomes and regulates and modulates numerous 
physiological functions and behaviors. Until now, three aminergic receptors have been cloned and 
experimentally examined from P. americana: an octopamine receptor [59], a tyramine receptor [60], 
and a serotonin receptor [61]. No dopamine receptor has been molecularly characterized to date. Here, 
we have cloned the cDNA encoding a dopamine receptor from P. americana, pharmacologically 
characterized the receptor, and investigated its expression profile. 
3.1. Receptor Variants Occur by Alternative Splicing of the Peadop2 Gene 
Splice variants have been described for a series of aminergic GPCRs, including dopamine receptors 
from Caenorhabditis elegans [68], the crustacean Panulirus interruptus [69], and the insect  
D. melanogaster [50]. Splice variants differ in their tissue distribution, ligand-binding properties,  
G-protein coupling, and activation of signaling pathways (for a review, see: [70]). Ono and  
Yoshikawa [66] have shown that the genomic structure of INDRs is highly conserved within the 
coding region. A large part of the receptor protein ranging from the N-terminus, up to and including 
TM7, is encoded by exon 1, whereas the C-terminal region is encoded by exons 2 and 3. The PeaDOP2 
variants identified in our study also belong to the INDR group of dopamine receptors (see below). 
Interestingly, a potential splice site is present at the site of divergence of the two isoforms. The 
Peadop2B variant most likely arises by retention of the intron following exon 1; this leads to an  
in-frame stop codon. Likewise, variants that possess truncated C-termini have been described in the 
orthologous receptor of the cat flea C. felis [67]. The two variants of the DOP2 receptor from  
D. melanogaster [53,54] also differ in their C-terminal sequence. Here, the difference arises in exon 3. 
Unfortunately, functional effects of the truncated C-terminus in C. felis or the differing C-termini in  
D. melanogaster DOP2 receptors have not been comparatively analyzed. Nevertheless, the high 
conservation of splice sites is in favor of a common ancestor of the INDR genes and also argues for 
high selection pressure retaining the functional variability by alternatively spliced INDR proteins. 
3.2. Structural Characteristics of the PeaDOP2 Receptor 
Based on bioinformatics, PeaDOP2 clearly belongs to the class of INDRs according to the 
nomenclature of Mustard et al. [19] (Figure 2). This dopamine receptor class is more closely  
related to α-adrenergic-like octopamine receptors than to mammalian D1-like receptors [19,58].  
Hauser et al. [71] have postulated that, during the evolution of aminergic GPCRs, new receptors 
evolved that needed new ligands. Because of structural constraints, one way in which to gain such 
ligands was to “borrow” them from related systems. This caused so-called “ligand-hops” between 
receptor families. Since INDRs are not only present in hemimetabolous (this work) and 
holometabolous [53–56,66,67,72] insects, but also in crustaceans [73], arachnids [74], and  
nematodes [68], this receptor class seems to be common for the Ecdysozoa group of protostome 
animals. Interestingly, the cephalochordate amphioxus (Branchiostoma floridae), which represents the 
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most basal of the chordates, also expresses a receptor, AmphiAmR2, showing close structural and 
pharmacological similarities to the INDRs [75]. 
The amino acid sequence of PeaDOP2 displays characteristic properties of amine-activated GPCRs 
in general and INDRs in particular [19]. The N-terminal region of the PeaDOP2 receptor contains four 
consensus sites for N-linked glycosylation (Figure 1). At least one of these sites is glycosylated when 
the protein is heterologously expressed in HEK 293 cells as monitored by PNGase F treatment and 
Western blotting (data not shown). 
PeaDOP2 contains four consensus sites for phosphorylation by protein kinase C. Thus, 
phosphorylation of PeaDOP2 can potentially lead to the uncoupling of the receptor from  
G-protein-dependent signaling pathways and/or the activation of G-protein-independent  
pathways [76]. The C-terminal region of PeaDOP2A contains three cysteine residues that allow 
palmitoylation and, thus, formation of a fourth CPL. Palmitoylation has previously been demonstrated 
for several human dopamine receptors [77–79]. The high degree of conservation of these cysteine 
residues in INDR sequences (Figure 1) argues in favor of their functional significance for, e.g., 
transport to the cell membrane and localization in lipid microdomains [77,80], optimal G-protein 
interaction [81,82], desensitization, and internalization processes [83], and possibly also receptor 
oligomerization [84]. In PeaDOP2B, these cysteine residues are lacking. 
Amino acid residues that are essential for dopamine binding are conserved in PeaDOP2. An aspartic 
acid in TM3 (D3.32; D151 in PeaDOP2) acts as a counter-ion for the protonated amino group of 
dopamine. Serine in TM5 forms hydrogen bonds with the catechol hydroxyl groups [64]. A tryptophan 
(W405) and a phenylalanine (F409) residue within the sequence motif C6.47-W6.48-x-P6.50-F6.51-F6.52 in 
TM6 interact with the aromatic ring of the ligand. This interaction modulates the bend angle of TM6 
around the highly conserved proline kink at Pro6.50, leading to a rotation or tilting movement of the 
cytoplasmic end of TM6 upon activation (for a review, see: [85]). The D3.49-R3.50-Y3.51 sequence at the 
start of CPL2, which is believed to play a key role in receptor activation (for a review, see: [85]), is 
also present in PeaDOP2 (D168RY). The signature motif N7.49-P7.50-x-x-Y7.53 in TM7 of GPCRs is 
additionally present in PeaDOP2 (N443PVIY). This motif is crucial for internalization, sequestration, 
ligand affinity, stabilization of the active conformation and thus receptor activation, and receptor 
signaling as revealed by numerous mutagenesis studies [86–89]. 
3.3. PeaDOP2A but Not PeaDOP2B Is a Functional Dopamine Receptor 
Activation of PeaDOP2A with dopamine leads to an increase in [cAMP]i, whereas tyramine, 
octopamine, serotonin, and histamine have no effect on [cAMP]i. The EC50 value of 160 nM for the 
dopamine-induced cAMP increase is similar to that of the D. melanogaster DOP2 receptor  
(350 nM, [54]). Most other insect DOP2 receptors have higher EC50 values (A. mellifera: 2.2 µM, [56]; 
C. felis: 2.4 µM, [67]; Bombyx mori: 1.3 µM, [90]). Thus, PeaDOP2A is a functional dopamine 
receptor with high affinity for dopamine. In contrast, dopamine stimulation of PeaDOP2B does not 
affect [cAMP]i. Neither PeaDOP2 receptor cause changes in [Ca2+]i upon dopamine incubation in the 
corresponding cell lines. This is in contrast to orthologous receptors from D. melanogaster and  
A. mellifera, which cause an increase both in [cAMP]i and in [Ca2+]i [53,58,91]. In summary, 
PeaDOP2A seems to couple exclusively to Gs proteins, whereas PeaDOP2B does not couple to any of 
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the classical G-protein-mediated signaling pathways and, therefore, might be considered as a  
non-functional receptor. 
However, our immunocytochemical analyses have shown that PeaDOP2B is translated and 
transported to the plasma membrane in HEK 293 cells (data not shown). Studies of various aminergic 
receptors suggest that truncated receptor variants might associate with full-length receptors and 
thereby modulate the binding and/or signal transduction properties in such heteromeric complexes. 
This has been shown, for example, for the D2-like receptor DOP-3 and its truncated splice variant 
DOP-3nf in C. elegans [68]. Because of an in-frame stop codon in the third intracellular loop,  
DOP-3nf lacks TM6 and TM7 of the full-length DOP-3 receptor [68]. DOP-3 attenuates  
forskolin-stimulated cAMP formation in response to dopamine stimulation, whereas DOP-3nf does  
not [68]. When DOP-3 was co-expressed with DOP-3nf, the ability to inhibit forskolin-stimulated 
cAMP formation was reduced [68]. Similar observations have been reported for human dopamine 
receptors and have been implicated in disease states such as schizophrenia [92–96]. Whether 
PeaDOP2B assembles and impairs PeaDOP2A function will be investigated in a forthcoming 
investigation and is beyond the scope of this study. 
3.4. Pharmacological Properties of the PeaDOP2A Receptor 
Early studies have shown that the pharmacological properties of dopamine receptors in the insect 
brain differ remarkably from those of their vertebrate counterparts [97,98]. This observation has been 
confirmed in detail for heterologously expressed dopamine receptors (for a review, see: [19]).  
In PeaDOP2A-expressing cells, treatments with non-selective dopamine receptor agonists (6,7-ADTN 
and apomorphine) and the D1-like receptor agonist 6-chloro-APB lead to an increase in [cAMP]i with 
a rank order of potency: 6,7-ADTN > dopamine > 6-chloro-APB > apomorphine. These agonists act 
similarly on INDRs from various insect species such as D. melanogaster (dopamine > 6-chloro-APB), 
A. mellifera (6,7-ADTN > 6-chloro-APB > dopamine > apomorphine), and B. mori (6,7-ADTN > 
dopamine > apomorphine) [53,56,90]. In contrast, the prototypical D1-like dopamine receptor partial 
agonist SKF 38393 does not show any effect on [cAMP]i in PeaDOP2A-expressing cells. This 
corresponds well to the lack of activity of SKF 38393 on all INDRs in insects [53,56,90]. The selective 
D2-like dopamine receptor agonist bromocriptine fails to increase [cAMP]i in PeaDOP2A-expressing 
cells. Since bromocriptine has been shown to be a potent agonist at insect D2-like receptors [37,50,52], 
it can be used pharmacologically to distinguish D2-like receptors from D1-like receptors and INDRs  
in insects. 
The non-selective antagonists flupentixol, chlorpromazine, and butaclamol, and the selective  
D1-like receptor antagonist SCH 23390 are able to counteract the dopamine-induced increase in 
[cAMP]i fully with the following inhibitory potency: flupentixol > chlorpromazine > butaclamol > 
SCH 23390 >> spiperone. This antagonist profile is remarkably similar to that of orthologous receptors 
from, e.g., D. melanogaster (flupentixol > SCH 23390 > butaclamol ≥ spiperone; [53]) and B. mori 
(flupentixol > chlorpromazine > SCH 23390 > butaclamol >> spiperone; [90]). The shared 
pharmacological profile between PeaDOP2A with that of INDRs from other insect species further 
supports its classification as a functional member of the INDR class. 
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3.5. Distribution of the PeaDOP2 Receptor in the Nervous System 
Peadop2 expression in the brain was examined by RT-PCR, Western blot analysis, and 
immunohistochemistry. At the mRNA level, both Peadop2A and Peadop2B were detected in the brain 
(Figure 3). An anti-PeaDOP2-antibody was raised against a region of the CPL3 and recognized both 
receptor variants. On Western blots containing membrane proteins from brain, subesophageal 
ganglion, and thoracic ganglia, two protein bands were immunostained (Figure 4) arguing in favor of 
the translation of both receptor proteins, i.e., PeaDOP2A/B. However, as long as no variant specific 
antibodies are available, it cannot be unequivocally ruled out that the occurrence of two protein bands 
is due to protein modification (e.g., glycosylation, degradation) or dimerization. 
In P. americana brain sections, the anti-PeaDOP2 antibody labels a cluster of neurons in the anterior 
border area of the medulla, a network of fibers in the optic lobes, and fibers in the ventrolateral 
protocerebrum and the optic commissures (Figure 5). In the locust Schistocerca gregaria, the somata 
of 18–20 dopamine-immunoreactive tangential neurons (DTan) are clustered at the anterior edge of the 
medulla [28]. The somata of these neurons are clustered at the anterior edge of the medulla. Their 
axons project via the first optic chiasma to the posterior edge of the lamina and give rise to dense 
arborizations in the proximal layer of the lamina with some processes extending into the distal  
layer [28]. Since the DTan neurons in S. gregaria and the PeaDOP2-immunoreactive neurons in  
P. americana share similar distribution patterns, future double-labeling experiments with the  
anti-dopamine and anti-PeaDOP2 antibodies would be worthwhile. A co-distribution of the two 
antigens would suggest an autoreceptor function for PeaDOP2, as has been described for mammalian 
dopamine receptors. 
The location of the PeaDOP2-immunoreactive cells between the central brain and the optic lobe is 
also reminiscent of the location of PDF (peptide dispersing factor)-expressing ventral lateral  
neurons (LNvs) described by Stengl and Homberg [99] in the cockroach Rhyparobia maderae. These 
neurons are members of the circadian clock circuitry. However, to determine whether PeaDOP2 
immunoreactive cells are indeed PDF-expressing clock neurons, double-labeling experiments with 
anti-PDF antibodies need to be performed. Co-expression of PeaDOP2 and PDF would suggest that 
dopamine acting via PeaDOP2 modulates PDF-positive LNvs and thus participates in the circadian 
behavior of cockroaches. 
The Peadop2 expression pattern in the brain is clearly distinct from that of orthologous INDRs in 
the holometabolous insects D. melanogaster, A. mellifera, and P. xuthus, as their INDRs are 
predominantly expressed in the mushroom bodies of the adult brain [54,55,72]. 
3.6. Possible Function of the PeaDOP2A Receptor in Saliva Generation and Secretion 
The salivary gland of P. americana is an established organotypic model for the investigation of the 
cellular actions of biogenic amines, since its secretory activity is regulated and modulated by dopamine 
and serotonin (for a recent review, see: [12]). Cockroaches have innervated acinar-type salivary glands 
with the secretory acini consisting of three cell types: peripheral cells (p-cells), central cells (c-cells), 
and centroacinar cells. Dopaminergic fibers project to the peripheral cells and salivary duct  
cells [30,100]. In isolated glands, dopamine leads to the secretion of protein-free saliva by activating 
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the peripheral cells [7]. In addition, dopamine affects the modification of primary saliva by stimulating 
salivary duct cells [101]. RT-PCR and Western blotting have revealed high expression levels of 
PeaDOP2 in the salivary glands. The pharmacological profile of dopamine-induced salivary secretion 
has been investigated in detail by Marg et al. [8]. Notably, the order of potency for agonists  
(6,7-ADTN > dopamine > 6-chloro-APB >> SKF 38393 = ineffective) and antagonists (flupentixol > 
chlorpromazine ≥ butaclamol) is the same as for the expressed PeaDOP2A receptor. Thus, the INDR, 
PeaDOP2, is a likely candidate in the mediation of the effects of dopamine on salivary secretion in 
cockroaches, although whether a true D1-like receptor is also involved in this process remains to  
be examined. 
In the migratory locust Locusta migratoria, dopamine induces hyperpolarization of salivary gland 
acinar cells [43] and salivary secretion [44]. The authors postulated that these effects are mediated via 
D1-like receptors [43,44]. Based on pharmacological experiments alone, however, it is difficult to 
decide whether a true D1-like receptor or an INDR mediates the effect of dopamine in the locust 
salivary gland. Dopamine also potently induces salivary secretion in isolated tick (Ixodes scapularis) 
salivary glands (for a recent review, see: [102]). Transcripts of a DOP1 receptor were found in salivary 
glands of I. scapularis [103]. Immunohistochemistry for the tick DOP1 receptor revealed scattered 
patches of reactivity in the junctions between cells on the luminal surface of specific secretory  
acini [102,103]. Recently, also an INDR was identified in I. scapularis [73] and found to be expressed 
in salivary glands, too [102]. 
4. Experimental Section  
4.1. Receptor Ligands 
Receptor ligands 5-hydroxytryptamine hydrochloride (5-HT), 6,7-ADTN hydrobromide, 
apomorphine hydrochloride hemihydrate, S(+)-butaclamol hydrochloride, 6-chloro-APB hydrobromide, 
cis(Z)-flupentixol dihydrochloride, dopamine hydrochloride, histamine dihydrochloride, (±)-octopamine 
hydrochloride, R(+)-SCH 23390 hydrochloride, R(+)-SKF 38393 hydrochloride, spiperone and 
tyramine hydrochloride were all purchased from Sigma (Taufkirchen, Germany). Chlorpromazine 
hydrochloride and bromocriptine mesylate were purchased from Enzo Life Sciences  
(Plymouth Meeting, PA, USA). 
4.2. Cloning of Peadop2 cDNA 
Based on sequence conservation throughout various arthropod species, degenerate primers  
(DF1: 5'-TGYTGGBTICCITTYTT-3'; DR1: 5'-RTTDAWVYAICCIARCC-3') were designed to 
amplify cDNA fragments of P. americana aminergic receptors [12,60,61]). Polymerase chain reaction 
(PCR) was performed on a P. americana-brain cDNA library [104] under the following conditions:  
1 cycle of 2.5 min at 94 °C, followed by 35 cycles of 40 s at 94 °C, 40 s at 45 °C, and 30 s at 72 °C, 
and a final extension of 10 min at 72 °C. The PCR products were cloned into pGEM-T vector 
(Promega, Mannheim, Germany) and subsequently analyzed by DNA sequencing (AGOWA,  
Berlin, Germany). A specific reverse primer derived from this sequence information  
(SR1: 5'-ACACAAGCTCCTCGTTCCAG-3') and an additional degenerate primer corresponding to a 
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sequence segment of TM2 (DF2: 5'-WSIYTIGCIRTIGCIG-3') were used for further PCR experiments. 
Missing 5'- and 3'-regions of the cDNA were amplified by SMART RACE (rapid amplification of 
cDNA ends) experiments (Clontech, Saint-Germain-en-Laye, France). Finally, PCR experiments were 
performed on single-stranded P. americana-brain cDNA to amplify the entire coding region of 
Peadop2A and Peadop2B by using gene-specific primers annealing in the 5'- and 3'-untranslated 
regions (SF: 5'-CCTAAAAAAGCGCAAGTGCGAG-3'; SRA: 5'-GGTGTGCTTACAGCGTG-3', 
SRB: 5'-GTGATAAGTTTGGTTAACACTGTC-3'). The nucleotide sequences of Peadop2A  
and Peadop2B have been submitted to the EBI database (Accession No.: HG794355 and  
HG794356, respectively). 
4.3. Multiple Sequence Alignment and Phylogenetic Analysis 
Amino acid sequences used for phylogenetic analyses were identified by protein-protein BLAST 
searches of the NCBI database with the deduced amino acid sequence of Peadop2A (PeaDOP2A) as 
“bait”. Multiple sequence alignments of the complete amino acid sequences were performed with 
ClustalW. Values for identity (ID) and similarity (S) were calculated by using the BLOSUM62 
substitution matrix in BioEdit 7.0.5 [105]. MEGA 4 [106] was used to calculate the genetic distances 
between the core sequences and to construct neighbor-joining trees with 2000-fold bootstrap  
re-sampling. The D. melanogaster ninaE-encoded rhodopsin 1 and FMRFamide receptor were used  
as outgroups. 
4.4. RT-PCR Amplification of Peadop2A and Peadop2B Fragments 
RT-PCR experiments to determine the tissue distribution of Peadop2A/B were performed as 
described earlier [10]. Briefly, receptor-specific fragments were amplified from 100 ng total RNA 
isolated from brain, salivary glands, midgut, Malpighian tubules, and leg muscle of adult male 
cockroaches. The sense primer was 5'-GCTGATACTATGTCTCCTC-3' (RT-F). The antisense 
primers were 5'-GAGTAGAGTTCGTGTTG-3' (RT-AR) and 5'-GGTTAACACTGTCATTC-3'  
(RT-BR) for Peadop2A and Peadop2B, respectively. Amplification resulted in fragments of the 
expected length of 554 and 455 bp for Peadop2A and Peadop2B, respectively. RT-PCR was  
also performed with actin-specific primers (Accession No. AY116670) as an internal control  
(ActinF: 5'-CGAGTAGCTCCTGAAGAGC-3'; ActinR: 5'-GGCCTCTGGACAACGGAACC-3'; 
fragment length: 488 bp). cDNA was synthesized for 30 min at 50 °C followed by a denaturation step 
at 94 °C for 2 min. Amplification was performed for 30 cycles at 94 °C for 40 s, 60 °C for 40 s, and  
72 °C for 40 s, followed by a final extension at 72 °C for 10 min. 
4.5. Antibody Production and Purification 
Antibodies were raised against a maltose-binding protein (MPB) containing a specific region of  
the 3rd cytoplasmic loop (CPL3) of PeaDOP2 (see Figure 1), which was constructed as follows.  
The CPL3-specific fragment was amplified by PCR with AB-F (5'-AAAGAATTCGCAGTAAT 
CCAGACG-3') and AB-R (5'-TTTGTCGACTCAGTGATGTGGAGGAGACAT-3') as the sense and 
antisense primer, respectively. The fragment was cloned into the pMAL-c2X vector (New England Biolabs, 
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Frankfurt, Germany). The fusion protein was over-expressed in E. coli BL21 and purified by  
amylose affinity-chromatography. Anti-PeaDOP2 polyclonal antiserum was raised in rabbits  
(Pineda-Antikörper-Service, Berlin, Germany). For purification of crude anti-PeaDOP2-antiserum, the 
CPL3-specific fragment of PeaDOP2 was cloned into the pET-30a vector (Novagen, Darmstadt, 
Germany) and over-expressed. The purified protein was coupled to a HiTrap NHS-activated High 
Performance column (GE Healthcare, Freiburg, Germany). Antibodies from 50 mL crude antiserum 
were affinity purified as described previously [60]. 
4.6. Western Blot Analysis 
Cockroach brains were homogenized in 150 µL Roti-load sample buffer (Roth, Karlsruhe, 
Germany) and incubated for 5 min at 95 °C. Alternatively, membrane proteins were isolated as 
described previously [61] and incubated for 5 min at 60 °C. Proteins were separated by 12%  
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Approximately 10 µg protein, as determined 
by a modified Bradford assay (Roti-Nanoquant, Roth, Karlsruhe, Germany), was run per lane and then 
transferred to polyvinylidene fluoride membranes (PVDF, Roth, Karlsruhe, Germany). PVDF 
membranes were labeled with antibodies as described previously [61] by applying anti-PeaDOP2 
(1:8000) followed by incubation with a secondary antibody conjugated to horseradish peroxidase 
(1:20,000; American Qualex, La Mirada, CA, USA). For controls, antibodies were pre-absorbed  
with the fusion protein (15 µg/mL) used for immunization. Immunoreactivity was detected by  
enhanced chemifluorescence. 
4.7. Immunofluorescence Staining of Brain Sections 
Dissected brains were fixed for 2 h in 3% paraformaldehyde, 0.075 M lysine HCl, 0.01 M sodium 
periodate, 0.2 M sucrose in 0.1 M phosphate buffer (pH 7.0). For immunofluorescence staining, 
preparations were rinsed in phosphate-buffered saline (PBS), transferred to 10% (w/v) sucrose in PBS 
for 1 h, incubated overnight in 25% sucrose in PBS at 4 °C, and frozen in melting isopentane  
(−155 °C). Sections (20 µm) were cut at −30 °C on a cryostat and collected on poly-L-lysine-coated 
cover-slips. The sections were successively incubated in 0.01% Tween 20 in PBS, 50 mM NH4Cl in 
PBS, PBS, and blocking solution containing 1% normal goat serum, 0.8% bovine serum albumin 
(BSA), and 0.5% Triton X-100 in PBS, with each step lasting 5 min at room temperature. Sections 
were then incubated overnight at 4 °C with anti-PeaDOP2 (1:800) diluted in blocking solution, washed 
for 3 × 10 min in PBS, and incubated with secondary antibodies for 1 h at room temperature. Sections 
were washed again for 3 × 10 min in PBS and mounted in Mowiol 4.88 (Hoechst, Frankfurt, Germany) 
containing 2% n-propyl gallate. Fluorescent images were recorded with a Zeiss LSM 510 confocal 
laser-scanning microscope (Carl Zeiss, Jena, Germany). 
4.8. Construction of pcPeadop2A/B-HA Expression Vector 
Expression-ready constructs of Peadop2A and Peadop2B cDNA were generated by PCR.  
To monitor transfection efficiency and receptor protein expression, a hemagglutinin (HA) epitope  
tag was engineered to the 3' end of each cDNA. First-round PCR was performed with a sense  
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primer 5'-GATTAAGCTTCCACCATGAACGGAAGCCTAGCAG-3' and the antisense  
primers 5'-TGGGACGTCGTATGGGTACATCGAGTAGAGTTCGTGTTG-3' (for Peadop2A) or  
5'-TGGGACGTCGTATGGGTACCTTCTGAAATCTCGACTCC-3' (for Peadop2B). In second-round 
PCR experiments, the same sense primer was used in combination with the antisense primer  
5'-TTTGGATCCTTAAGCGTAGTCTGGGACGTCGTATGGG-3'. PCR products were digested with 
Bam HI and Hind III and sub-cloned into pcDNA3.1(+) vector (Invitrogen, Karlsruhe, Germany) yielding 
pcPeadop2A-HA and pcPeadop2B-HA. The correct insertion was confirmed by DNA sequencing. 
4.9. Functional Expression of the PeaDOP2A/B-HA Receptor 
Approximately 8 µg pcPeadop2A/B-HA vector was separately introduced into exponentially 
growing HEK 293 cells (~4 × 105 cells per 5 cm Petri dish; Greiner, Frickenhausen, Germany) by a 
modified calcium phosphate method [107]. Stably transfected cells were selected in the presence of the 
antibiotic G418 at 0.8 mg/mL. Isolated foci were propagated and analyzed for the expression of 
PeaDOP2A/B-HA by immunocytochemistry and Western blot analysis with a commercial anti-HA 
antibody (anti-HA high affinity; Roche, Penzberg, Germany). 
4.10. Functional Characterization of PeaDOP2A and PeaDOP2B Receptors 
Assays to determine the ability of PeaDOP2A/B-HA receptors to stimulate adenylyl cyclase activity 
were performed as described earlier [108]. PeaDOP2A/B-expressing cells were grown in minimal 
essential medium with GlutaMAX™ (Invitrogen, Karlsruhe, Germany), 10% (v/v) fetal bovine serum, 
1% (v/v) non-essential amino acids, and antibiotics (all from Invitrogen, Karlsruhe, Germany). Cells 
were incubated with ligands for 30 min at 37 °C in the presence of the phosphodiesterase inhibitor 
isobutylmethylxanthine (IBMX; Sigma, Taufkirchen, Germany; final concentration 100 µM) and lysed 
by adding 0.5 mL ice-cold ethanol. After 1 h at 4 °C, the lysate was transferred to a reaction tube and 
lyophilized. The amount of cAMP produced was determined by using the TRK 432 cyclic AMP assay 
kit (GE Healthcare, Freiburg, Germany). Data were analyzed and displayed by using PRISM 4.01 
software (GraphPad, San Diego, CA, USA). 
5. Conclusions 
Cockroaches are established model organisms for studying circadian rhythms [4], insect learning [16], 
and the aminergic control and modulation of salivary secretion [12]. The pharmacological characterization 
and tissue localization of the first dopamine receptor provides the basis for forthcoming studies 
examining its role in cockroach behavior and physiology. Interference with PeaDOP2 expression by 
applying the RNAi technique or receptor activation with specific PeaDOP2 ligands can be used to 
unravel its contribution to rhythmic behavioral patterns and memory formation in this insect. 
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